Podlesak Dennis bought SNDX
August 18, 2025 · Form 4 insider transaction
Podlesak Dennis bought 19,200 shares of Syndax Pharmaceuticals, Inc. at $7.20 per share, a transaction worth $138.2K. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 0 days after the transaction.
Direction
Acquired (buy-side)
Shares
19,200
Price
$7.20
Total value
$138.2K
InsiderPodlesak Dennis
RoleDirector
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateAugust 18, 2025
Filing dateAugust 18, 2025
Shares owned after210,963
OwnershipDirect
10b5-1 planNo
AmendedNo